Professor Rob Howard (UCL Psychiatry) explains the complexities of treating people with Alzheimer’s disease in the wake of medical trials involving the breakthrough drug donanemab that could slow the progression of the disease.
Listen: BBC Radio 4 ‘More or Less’ (from 19 mins 38 secs)
Close
